CClinicalTrials.gg
CompletedNCT01146236Updated Oct 17, 2018

Sutures Versus Staples for Wound Closure in Orthopaedic Surgery

An interventional study of Sutures and Staples in Surgical Wound Infection, sponsored by University of Manitoba. Completed at 3 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-17.

Sponsored by University of Manitoba · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
247
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The trial is a randomized, controlled trial. Adult patients undergoing orthopaedic surgical procedures would be randomized to one of two groups for surgical wound closure, skin sutures or skin staples. The primary outcome measures would be surgical site infection indicated by the use of oral or intravenous antibiotics for suspected wound infection and/or re-operation at the same site. Patients would be followed up as per their usual post-operative course for a total of three months in the trauma and spine population and six months in the total joint arthroplasty population. It is hypothesized that wounds closed with sutures and staples will have similar infection rates as defined by the use of antibiotics or reoperation.

Read the detailed description

To date, there is no clear consensus on the method that is best for closure of surgical wounds in orthopaedic surgery. Orthopaedic surgeons have a multitude of wound closure habits. A recent meta-analysis comparing staples to sutures in wound closure demonstrated a three-fold increase in infection in stapled wounds compared to sutured wounds. The studies used in the meta-analysis were primarily of poor methodological quality.

A large, well-designed randomized, controlled trial is needed to guide orthopedic surgeons in their choice of wound closure materials. This study would attempt to provide information on the use of sutures versus skin staples and the effect on the development of surgical site infections in adults undergoing orthopaedic procedures.

A parallel group randomized controlled trial with institutional review board approval will be conducted. Patients will be randomized intraoperatively to have skin wounds closed with sutures or staples. Dressings will be used to maintain blinding of participants and outcome assessors. The primary outcome measure will be infections adjudicated by a blinded data safety monitoring committee. Suspected infections will be defined by: Use of antibiotics or reoperation for infection at the operative site within three months (six months for arthroplasty subgroup) The independent review, board blinded to treatment assignment, will adjudicate suspected infections based on clinical data. A cost analysis will also be performed to compare the costs associated with wounds closed with sutures and staples from a health care institution perspective.

All data will be analyzed by a blinded epidemiologist. Dichotomous primary and secondary outcome measures will be analyzed using the Chi-squared statistic. Continuous outcome measures will be analyzed using Student's t-test. Subgroup analysis will compare infection rates using sutures versus staples in each anatomic area (upper extremity, pelvis/acetabulum, hip/femur, knee, ankle). A further subgroup analysis will be conducted comparing trauma patients to elective patients. Non-infected revision surgery will also be compared to primary surgery.

It is hypothesized that wounds closed with sutures and staples will have similar infection rates as defined by the use of antibiotics or reoperation.

02

Conditions studied

  • Surgical Wound Infection

Keywords

  • Surgical
  • Infection
  • Post-operative
  • Sutures
  • Staples
03

In context

Wound Infection

382 studies on the registry are indexed under Wound Infection; 40 are open to participants now.

This study's enrollment of 247 is above the median of 150 across 296 interventional studies indexed under Wound Infection.

Browse Wound Infection studies →

Lead sponsor

University of Manitoba is the lead sponsor of 542 studies on the registry; 87 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients (>18 years old)
  • All open orthopedic procedures
  • Largest wound >2cm in length

Exclusion criteria

Exclusion Criteria:

  • Open fracture
  • Known nickel allergy
  • Active infection (any site)
  • Chemotherapy during study period (1 month prior until end of follow-up)
  • Radiation therapy to surgical site (1 month prior until end of follow-up)
  • Foot surgery (any site)
  • Hand surgery (including carpal surgery)
  • Arthroscopic procedures
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
247 participants (actual)

Study arms

  • Active comparator
    Sutures

    Orthopedic surgical wound closed with sutures

    Device: Sutures

  • Active comparator
    Staples

    Orthopedic surgical wound closed with metallic staples

    Device: Staples

Interventions

  • DeviceSutures

    Orthopedic surgical wounds closed with sutures

  • DeviceStaples

    Orthopedic surgical wounds closed with metallic staples

06

What researchers measure

Primary outcomes

  1. Surgical site infection

    Suspected cases will be identified by one or all of the following: use of intravenous antibiotics, use of oral antibiotics (patient self-reported), re-operation at same site. A blinded committee will adjudicate each suspected case and determine true infections using available clinical information. Agreement will be determined by vote.

    Time frame: 6 months

Secondary outcomes

  1. Additional healthcare contact related to their surgery

    As defined by self-reported visits to other healthcare professionals.

    Time frame: 6 months

  2. Dressing changes by homecare/patient at home

    Defined by homecare consult records and patient self-report

    Time frame: 6 months

  3. Length of stay

    Based on admission and discharge dates

    Time frame: 6 months

  4. Wound drainage

    As defined by necessity for dressing changes after 72 hours for fluid leakage

    Time frame: 6 months

  5. Wound necrosis

    Evidence of marginal skin death at the surgical site as evidenced by skin slough, blackening or liquefaction

    Time frame: 6 months

  6. Patient satisfaction with wound appearance

    Using visual analogue scale

    Time frame: 6 months

  7. Visual analogue pain score for suture/staple removal

    Patients will rate the pain experienced in removing the wound closure materials in clinic prior to unblinding.

    Time frame: 2 weeks post-operative

07

Study locations

3 sites
  • Concordia Hip and Knee Institute
    Winnipeg, Manitoba R2K 2M9, Canada
  • Health Sciences Centre
    Winnipeg, Manitoba R3A 1R9, Canada
  • Pan Am Clinic
    Winnipeg, Manitoba R3M 3E4, Canada
08

References and documents

Publications

  • Slade Shantz JA, Vernon J, Morshed S, Leiter J, Stranges G. Sutures versus staples for wound closure in orthopaedic surgery: a pilot randomized controlled trial. Patient Saf Surg. 2013 Feb 9;7(1):6. doi: 10.1186/1754-9493-7-6. PubMed 23394586 ↗
  • Shantz JA, Vernon J, Leiter J, Morshed S, Stranges G. Sutures versus staples for wound closure in orthopaedic surgery: a randomized controlled trial. BMC Musculoskelet Disord. 2012 Jun 6;13:89. doi: 10.1186/1471-2474-13-89. PubMed 22672186 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01146236
Lead sponsor
University of Manitoba
Collaborators
Manitoba Medical Service Foundation, Gibson Orthopaedic Fund for Research and Education
Responsible party
Dr. Jesse Shantz (Orthopedic Surgeon, University of Manitoba) — Principal investigator
First posted
Jun 17, 2010
Start date
Jul 2010
Primary completion
Sep 2013
Completion
Dec 2013
Last update
Oct 17, 2018

Study contacts

Jesse Shantz, MD, MBA
principal investigator · University of Manitoba

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion